55 related articles for article (PubMed ID: 9630842)
21. A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion.
Santos J; González-Sánchez L; Matabuena-Deyzaguirre M; Villa-Morales M; Cozar P; López-Nieva P; Fernández-Navarro P; Fresno M; Díaz-Muñoz MD; Guenet JL; Montagutelli X; Fernández-Piqueras J
Cancer Res; 2009 Mar; 69(6):2577-87. PubMed ID: 19244132
[TBL] [Abstract][Full Text] [Related]
22. Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor tolerance.
Robinson BW; Scott BM; Lake RA; Stumbles PA; Nelson DJ; Fisher S; Marzo AL
Clin Cancer Res; 2001 Mar; 7(3 Suppl):811s-817s. PubMed ID: 11300477
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
Hata H; Uenaka A; Takada I; Kenjo A; Takahashi M; Ono T; Fujita T; Nakayama E
Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
[TBL] [Abstract][Full Text] [Related]
25. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity mediated by double-negative T cells.
Young KJ; Kay LS; Phillips MJ; Zhang L
Cancer Res; 2003 Nov; 63(22):8014-21. PubMed ID: 14633734
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis during the development of radiogenic thymic lymphomas: effects of treatments inhibiting lymphoma development.
Humblet C; Denis G; Greimers R; Boniver J; Defresne MP
Anticancer Res; 1998; 18(5A):3469-74. PubMed ID: 9858926
[TBL] [Abstract][Full Text] [Related]
28. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
29. Functional Fas (Cd95/Apo-1) promoter polymorphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-induced thymic lymphoma.
Villa-Morales M; Santos J; Fernández-Piqueras J
Oncogene; 2006 Mar; 25(14):2022-9. PubMed ID: 16301997
[TBL] [Abstract][Full Text] [Related]
30. Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
Sanchez-Perez L; Kottke T; Diaz RM; Ahmed A; Thompson J; Chong H; Melcher A; Holmen S; Daniels G; Vile RG
Cancer Res; 2005 Mar; 65(5):2009-17. PubMed ID: 15753401
[TBL] [Abstract][Full Text] [Related]
31. Multiple pre-neoplastic events and clonal selection of radiation induced mouse thymic lymphomas shown by TCR gene rearrangements.
Shimizu T; Muto M; Kubo E; Sado T; Yamagishi H
Leuk Res; 1993 Nov; 17(11):959-65. PubMed ID: 8231236
[TBL] [Abstract][Full Text] [Related]
32. T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL.
Leishman AJ; Naidenko OV; Attinger A; Koning F; Lena CJ; Xiong Y; Chang HC; Reinherz E; Kronenberg M; Cheroutre H
Science; 2001 Nov; 294(5548):1936-9. PubMed ID: 11729321
[TBL] [Abstract][Full Text] [Related]
33. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
34. TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.
Wong CP; Okada CY; Levy R
J Immunol; 1999 Feb; 162(4):2251-8. PubMed ID: 9973501
[TBL] [Abstract][Full Text] [Related]
35. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
36. Characteristic association between K-ras gene mutation with loss of heterozygosity in X-ray-induced thymic lymphomas of the B6C3F1 mouse.
Shimada Y; Nishimura M; Kakinuma S; Takeuchi T; Ogiu T; Suzuki G; Nakata Y; Sasanuma S; Mita K; Sado T
Int J Radiat Biol; 2001 Apr; 77(4):465-73. PubMed ID: 11304438
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice.
Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T
Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of surface markers on thymic lymphomas induced by two carcinogenic agents in different mouse strains.
Diamond LE; Berman JW; Pellicer A
Cell Immunol; 1987 Jun; 107(1):115-20. PubMed ID: 2884044
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of Ran/TC4 as a protein regulating T-cell costimulation.
Nieland JD; Haks MC; Kremers BL; Leupers TJ; Bakker AQ; Offringa R; Kruisbeek AM
Cancer Gene Ther; 1998; 5(5):259-73. PubMed ID: 9824045
[TBL] [Abstract][Full Text] [Related]
40. Immunological investigation of the prelymphoma period in baboons of the Sukhumi monkey stock.
Lapin BA; Voevodin AF; Indzhiia LV; Yakovleva LA; Ponomarjeva TI
Exp Pathol; 1983; 24(2-3):91-6. PubMed ID: 6605878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
